Neurizon doses first patient with NUZ-001 in amyotrophic lateral sclerosis trial
NUZ|Bullish|26 Feb 2026 · 5 days ago
Read More →Want to know today's top companies with the most bullish news? Subscribe to our FREE newsletter
1 article · filtered by NUZ